Welcome to our dedicated page for AIBotics SEC filings (Ticker: AIBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how AIBotics funds cutting-edge robotics, capitalises software R&D, or times product launches is tough when those details are buried deep in technical disclosures. Even seasoned analysts can spend hours pulling segment data or matching patent language to future revenue streams.
Our platform solves that problem. Stock Titan instantly parses every AIBotics annual report 10-K simplified, highlights the R&D footnotes in each AIBotics quarterly earnings report 10-Q filing, and flags AIBotics 8-K material events explained the moment they hit EDGAR. AI-powered summaries translate jargon into plain English, so understanding AIBotics SEC documents with AI becomes straightforward. Need to monitor leadership moves? Receive AIBotics Form 4 insider transactions real-time and analyse buying or selling trends through the lens of product rollouts.
You’ll also find:
- AIBotics insider trading Form 4 transactions with contextual AI commentary
- AIBotics proxy statement executive compensation breakdowns to see how bonuses align with innovation goals
- AIBotics earnings report filing analysis comparing hardware margins to software licensing growth
Aibotics, Inc. (AIBT) reported another loss-making quarter for Q3 2025 with almost no revenue and a heavy debt load. The company generated no revenue in the quarter and only $2,183 for the first nine months of 2025, while recording a net loss of $529,921 for Q3 and $1,607,467 for the nine-month period, slightly higher than a year ago.
At September 30, 2025, Aibotics held $230,470 in cash against current liabilities of $4,902,572, resulting in a working capital deficit of $4,661,176 and a stockholders’ deficit of $3,885,629. Management states these conditions raise “substantial doubt” about the company’s ability to continue as a going concern.
To meet obligations, Aibotics relied on issuing and converting large amounts of common stock, expanding outstanding shares from 39,990,903 at December 31, 2024 to 318,890,559 at September 30, 2025, with further issuances after quarter-end. Several convertible notes remain in default, and the company continues to depend on new debt and equity financing.
Aibotics Inc. (AIBT) filed a Form 12b-25 (NT 10-Q) for the quarter ended September 30, 2025, notifying a late quarterly report. The company cites the need for additional time for auditor review. Under Rule 12b-25(b), it expects to file the Form 10-Q on or before the fifth calendar day following the prescribed due date. The notice lists Jonathan Leinwand as the contact and is signed by CEO and CFO Ben Kaplan.
FAQ
What is the current stock price of AIBotics (AIBT)?
What is the market cap of AIBotics (AIBT)?
